Although B02 is not tumor-specific in its uptake, previous studies have shown that non-malignant cells are less reliant on HR and thus exhibit reduced sensitivity to RAD51 inhibition under sublethal DNA damage conditions [28, 38]. Here, RAD51 is linked to neoplasm.